Skip to Content
Merck
  • Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses.

Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses.

Journal of proteomics (2013-02-05)
Abul Hasan Sardar, Sudeep Kumar, Ashish Kumar, Bidyut Purkait, Sushmita Das, Abhik Sen, Manish Kumar, Kislay Kumar Sinha, Dharmendra Singh, Asif Equbal, Vahab Ali, Pradeep Das
ABSTRACT

Phagocytic cells produce reactive oxygen and nitrogen species (ROS & RNS) as the most common arsenal to kill intracellular pathogens. Leishmania, an obligate intracellular pathogen also confronts this antimicrobial assault during the early phase of infection but nevertheless is able to survive these attacks and proliferate in macrophage. Adaptation of Leishmania to the toxic effects of ROS and RNS, involves a rapid change in the parasite proteome to combat the host defense response that macrophage mount in combating pathogen. To understand the events associated with combating ROS and RNS species, we performed a proteomic analysis of L. donovani promastigotes treated with sub-lethal doses of menadione (ROS), S-nitroso-N-acetylpenicillamine (RNS) or combination of both compounds. Proteomic changes triggered by these reagents were evaluated by iTRAQ labeling and subsequent LC-MALDI-TOF/TOF-MS analysis. Across the 3 stress conditions, the quantitative analysis identified changes in the proteins which encompass ~20% of the parasite proteome. Major changes were observed in enzymatic machinery of pathways involved in maintaining redox homeostasis, trypanothione metabolism, oxidative phosphorylation, superoxide metabolism, mitochondrial respiration process and other essential metabolic pathways. These observations shed light on how Leishmania promastigotes counter ROS and RNS effects during the initial stage of infection. This article is part of a Special Issue entitled: From protein structures to clinical applications.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Menadione sodium bisulfite, BioReagent, suitable for cell culture, ≥95% (TLC)
Sigma-Aldrich
Menadione sodium bisulfite, ≥95% (TLC)
Menadione, European Pharmacopoeia (EP) Reference Standard
Supelco
Menadione (K3), analytical standard
Sigma-Aldrich
Menadione, crystalline
Sigma-Aldrich
Menadione, meets USP testing specifications